Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes

Neuropharmacology

Volumn 85, Issue , 2014, Pages 499-507

  Cisneros, Irma E ^a   Ghorpade, Anuja ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Astrocytes; cAMP; Human immunodeficiency virus 1; Methamphetamine; Trace amine associated receptor 1

Indexed keywords

CYCLIC AMP; EXCITATORY AMINO ACID TRANSPORTER 2; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; METHAMPHETAMINE; PHENETHYLAMINE; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG; CENTRAL NERVOUS SYSTEM AGENTS; FORSKOLIN; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; PHENETHYLAMINE DERIVATIVE; SLC1A2 PROTEIN, HUMAN; TRACE AMINE-ASSOCIATED RECEPTOR 1;

ARTICLE; ASTROCYTE; CELL LEVEL; CLEARANCE; CONTROLLED STUDY; EXCITOTOXICITY; GENE EXPRESSION; GENE SILENCING; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NERVE FUNCTION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; AGONISTS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

ASTROCYTES; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; COLFORSIN; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE KNOCKDOWN TECHNIQUES; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; HIV INFECTIONS; HIV-1; HUMANS; METHAMPHETAMINE; PHENETHYLAMINES; RECEPTORS, G-PROTEIN-COUPLED; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84903826066     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.06.011     Document Type: Article

References (63)

1. E.M. Aandahl, P. Aukrust, B.S. Skalhegg, F. Muller, S.S. Froland, V. Hansson, and K. Tasken Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients FASEB J. 12 1998 855 862 (Pubitemid 28294675)
2. Y. Aida, K. Honda, S. Tanigawa, G. Nakayama, H. Matsumura, N. Suzuki, O. Shimizu, O. Takeichi, M. Makimura, and M. Maeno IL-6 and soluble IL-6 receptor stimulate the production of MMPs and their inhibitors via JAK-STAT and ERK-MAPK signalling in human chondrocytes Cell Biol. Int. 36 4 2012 367 376
3. S.G. Amara, and A.C. Fontana Excitatory amino acid transporters: keeping up with glutamate Neurochem. Int. 41 2002 313 318
4. C.M. Anderson, and R.A. Swanson Astrocyte glutamate transport: review of properties, regulation, and physiological functions Glia 32 2000 1 14
5. L.S. Barak, A. Salahpour, X. Zhang, B. Masri, T.D. Sotnikova, A.J. Ramsey, J.D. Violin, R.J. Lefkowitz, M.G. Caron, and R.R. Gainetdinov Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor Mol. Pharmacol. 74 2008 585 594
6. K. Blackstone, J.E. Iudicello, E.E. Morgan, E. Weber, D.J. Moore, D.R. Franklin, R.J. Ellis, I. Grant, and S.P. Woods Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use J. Addict. Med. 7 4 2013 255 263
7. B. Boivin, G. Vaniotis, B.G. Allen, and T.E. Hebert G protein-coupled receptors in and on the cell nucleus: a new signaling paradigm? J. Recept. Signal Transduct. Res. 28 2008 15 28 (Pubitemid 351588071)
8. J.R. Bunzow, M.S. Sonders, S. Arttamangkul, L.M. Harrison, G. Zhang, D.I. Quigley, T. Darland, K.L. Suchland, S. Pasumamula, J.L. Kennedy, S.B. Olson, R.E. Magenis, S.G. Amara, and D.K. Grandy Amphetamine, 3,4- methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor Mol. Pharmacol. 60 2001 1181 1188 (Pubitemid 33144888)
9. M. Casado, A. Bendahan, F. Zafra, N.C. Danbolt, C. Aragon, C. Gimenez, and B.I. Kanner Phosphorylation and modulation of brain glutamate transporters by protein kinase C J. Biol. Chem. 268 1993 27313 27317 (Pubitemid 24006452)
10. T. Chadderton, C. Wilson, M. Bewick, and S. Gluck Evaluation of three rapid RNA extraction reagents: relevance for use in RT-PCR's and measurement of low level gene expression in clinical samples Cell Mol. Biol. (Noisy-le-grand) 43 1997 1227 1234
11. I.E. Cisneros, and A. Ghorpade HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS Curr. HIV Res. 10 2012 392 406
12. C.K. Colton, Q. Kong, L. Lai, M.X. Zhu, K.I. Seyb, G.D. Cuny, J. Xian, M.A. Glicksman, and C.L. Lin Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity J. Biomol. Screen. 15 2010 653 662
13. R.J. Ellis, M.E. Childers, M. Cherner, D. Lazzaretto, S. Letendre, and I. Grant Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy J. Infect. Dis. 188 2003 1820 1826 (Pubitemid 38064866)
14. D.D. Fraser, L.A. Mudrick-Donnon, and B.A. MacVicar Astrocytic GABA receptors Glia 11 1994 83 93 (Pubitemid 2116295)
15. A. Gadea, and A.M. Lopez-Colome Glial transporters for glutamate, glycine and GABA I. Glutamate transporters J. Neurosci. Res. 63 2001 453 460 (Pubitemid 32193702)
16. R.R. Gainetdinov, A.R. Mohn, and M.G. Caron Genetic animal models: focus on schizophrenia Trends Neurosci. 24 2001 527 533 (Pubitemid 32744707)
17. J. Gardner, K. Borgmann, M.S. Deshpande, A. Dhar, L. Wu, R. Persidsky, and A. Ghorpade Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases J. Neurosci. Res. 83 2006 1281 1292 (Pubitemid 43668011)
18. H.E. Gendelman, P. Genis, M. Jett, Q.H. Zhai, and H.S. Nottet An experimental model system for HIV-1-induced brain injury Adv. Neuroimmunol. 4 1994 189 193 (Pubitemid 24325863)
19. J. Glowinski, P. Marin, M. Tence, N. Stella, C. Giaume, and J. Premont Glial receptors and their intervention in astrocyto-astrocytic and astrocyto-neuronal interactions Glia 11 1994 201 208
20. F. Gobeil, A. Fortier, T. Zhu, M. Bossolasco, M. Leduc, M. Grandbois, N. Heveker, G. Bkaily, S. Chemtob, and D. Barbaz G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm Can. J. Physiol. Pharmacol. 84 2006 287 297 (Pubitemid 44481092)
21. G.E. Gochenauer, and M.B. Robinson Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L-[3H]glutamate transport and expression of both system xc(-) subunits J. Neurochem. 78 2001 276 286 (Pubitemid 32664409)
22. N.V. Harris, H. Thiede, J.P. McGough, and D. Gordon Risk factors for HIV infection among injection drug users: results of blinded surveys in drug treatment centers, King County, Washington 1988-1991 J. Acquir. Immune Defic. Syndr. 6 1993 1275 1282 (Pubitemid 23314403)
23. B. Hofmann, P. Nishanian, T. Nguyen, M. Liu, and J.L. Fahey Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues Aids 7 1993 659 664 (Pubitemid 23204958)
24. A. Kalandadze, Y. Wu, and M.B. Robinson Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486 J. Biol. Chem. 277 2002 45741 45750 (Pubitemid 35417550)
25. P. Karki, A. Webb, K. Smith, K. Lee, D.S. Son, M. Aschner, and E. Lee cAMP response element-binding protein (CREB) and nuclear factor kappaB mediate the tamoxifen-induced up-regulation of glutamate transporter 1 (GLT-1) in rat astrocytes J. Biol. Chem. 288 2013 28975 28986
26. K. Kim, S.G. Lee, T.P. Kegelman, Z.Z. Su, S.K. Das, R. Dash, S. Dasgupta, P.M. Barral, M. Hedvat, P. Diaz, J.C. Reed, J.L. Stebbins, M. Pellecchia, D. Sarkar, and P.B. Fisher Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics J. Cell. Physiol. 226 2011 2484 2493
27. H.K. Kimelberg Receptors on astrocytes-what possible functions? Neurochem. Int. 26 1995 27 40
28. C.C. King, M. Sastri, P. Chang, J. Pennypacker, and S.S. Taylor The rate of NF-kappaB nuclear translocation is regulated by PKA and A kinase interacting protein 1 PLoS One 6 2011 e18713
29. E.A. Kiyatkin, and H.S. Sharma Environmental conditions modulate neurotoxic effects of psychomotor stimulant drugs of abuse Int. Rev. Neurobiol. 102 2012 147 171
30. A.H. Lewin Receptors of mammalian trace amines AAPS J. 8 2006 E138 E145
31. K.A. Lindl, D.R. Marks, D.L. Kolson, and K.L. Jordan-Sciutto HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities J. Neuroimmune Pharmacol. Off. J. Soc. Neuroimmune Pharmacol. 5 2010 294 309
32. Q.S. Liu, Q. Xu, G. Arcuino, J. Kang, and M. Nedergaard Astrocyte-mediated activation of neuronal kainate receptors Proc. Natl. Acad. Sci. U. S. A. 101 2004 3172 3177 (Pubitemid 38327753)
33. M. Manthrope, R. Fagnani, S.D. Skaper, and S. Varon An automated colorimetric microassay for neurotrophic factors Dev. Brain Res. 25 1986 191 198 (Pubitemid 16188172)
34. J.F. Marshall, and S.J. O'Dell Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci. 35 2012 536 545
35. J. Martinez-Villarreal, N. Garcia Tardon, I. Ibanez, C. Gimenez, and F. Zafra Cell surface turnover of the glutamate transporter GLT-1 is mediated by ubiquitination/deubiquitination Glia 60 2012 1356 1365
36. J.J. Miguel-Hidalgo The role of glial cells in drug abuse Curr. Drug Abuse Rev. 2 2009 76 82
37. G.M. Miller, C.D. Verrico, A. Jassen, M. Konar, H. Yang, H. Panas, M. Bahn, R. Johnson, and B.K. Madras Primate trace amine receptor 1 modulation by the dopamine transporter J. Pharmacol. Exp. Ther. 313 2005 983 994 (Pubitemid 40727001)
38. M.E. Moreno-Fernandez, C.M. Rueda, P.A. Velilla, M.T. Rugeles, and C.A. Chougnet cAMP during HIV infection: friend or foe? AIDS Res. Hum. Retroviruses 28 2012 49 53
39. T. Nagai, and K. Yamada Molecular mechanism for methamphetamine-induced memory impairment Nihon Arukoru Yakubutsu Igakkai Zasshi 45 2010 81 91
40. D.A. Nelson, M.D. Tolbert, S.J. Singh, and K.L. Bost Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes J. Neuroimmunol. 192 2007 21 30 (Pubitemid 350213111)
41. M. Nokta, and R. Pollard Human immunodeficiency virus infection: association with altered intracellular levels of cAMP and cGMP in MT-4 cells Virology 181 1991 211 217
42. M.W. Panas, Z. Xie, H.N. Panas, M.C. Hoener, E.J. Vallender, and G.M. Miller Trace amine associated receptor 1 signaling in activated lymphocytes J. Neuroimmune Pharmacol. 7 2012 866 876
43. V. Paramanik, and M.K. Thakur Role of CREB signaling in aging brain Arch. Ital. Biol. 151 2013 33 42
44. J.D. Pita-Almenar, M.S. Collado, C.M. Colbert, and A. Eskin Different mechanisms exist for the plasticity of glutamate reuptake during early long-term potentiation (LTP) and late LTP J. Neurosci. 26 2006 10461 10471 (Pubitemid 44564596)
45. J.T. Porter, and K.D. McCarthy Astrocytic neurotransmitter receptors in situ and in vivo Prog. Neurobiol. 51 1997 439 455 (Pubitemid 27170170)
46. R. Potula, B.J. Hawkins, J.M. Cenna, S. Fan, H. Dykstra, S.H. Ramirez, B. Morsey, M.R. Brodie, and Y. Persidsky Methamphetamine causes mitochondrial oxidative damage in human T lymphocytes leading to functional impairment J. Immunol. 185 2010 2867 2876
47. F.G. Revel, J.L. Moreau, R.R. Gainetdinov, A. Bradaia, T.D. Sotnikova, R. Mory, S. Durkin, K.G. Zbinden, R. Norcross, C.A. Meyer, V. Metzler, S. Chaboz, L. Ozmen, G. Trube, B. Pouzet, B. Bettler, M.G. Caron, J.G. Wettstein, and M.C. Hoener TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity Proc. Natl. Acad. Sci. U. S. A. 108 2011 8485 8490
48. F.G. Revel, J.L. Moreau, B. Pouzet, R. Mory, A. Bradaia, D. Buchy, V. Metzler, S. Chaboz, K. Groebke Zbinden, G. Galley, R.D. Norcross, D. Tuerck, A. Bruns, S.R. Morairty, T.S. Kilduff, T.L. Wallace, C. Risterucci, J.G. Wettstein, and M.C. Hoener A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight Mol. Psychiatry 18 2013 543 556
49. J.D. Rippeth, R.K. Heaton, C.L. Carey, T.D. Marcotte, D.J. Moore, R. Gonzalez, T. Wolfson, and I. Grant Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons J. Int. Neuropsychol. Soc. 10 2004 1 14 (Pubitemid 38128457)
50. K.R. Rodvelt, and D.K. Miller Could sigma receptor ligands be a treatment for methamphetamine addiction? Curr. Drug Abuse Rev. 3 2010 156 162
51. B.D. Schlag, J.R. Vondrasek, M. Munir, A. Kalandadze, O.A. Zelenaia, J.D. Rothstein, and M.B. Robinson Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons Mol. Pharmacol. 53 1998 355 369 (Pubitemid 28162855)
52. K.C. Schmitt, and M.E. Reith Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse Ann. N. Y. Acad. Sci. 1187 2010 316 340
53. S.J. Semple, T.L. Patterson, and I. Grant Motivations associated with methamphetamine use among HIV+ men who have sex with men J. Subst. Abuse Treat. 22 2002 149 156 (Pubitemid 34597219)
54. M.V. Sofroniew, and H.V. Vinters Astrocytes: biology and pathology Acta Neuropathol. 119 2010 7 35
55. J. Tan, O. Zelenaia, D. Correale, J.D. Rothstein, and M.B. Robinson Expression of the GLT-1 subtype of Na+-dependent glutamate transporter: pharmacological characterization and lack of regulation by protein kinase C J. Pharmacol. Exp. Ther. 289 1999 1600 1610 (Pubitemid 29246696)
56. G. Tian, L. Lai, H. Guo, Y. Lin, M.E. Butchbach, Y. Chang, and C.L. Lin Translational control of glial glutamate transporter EAAT2 expression J. Biol. Chem. 282 2007 1727 1737 (Pubitemid 47076686)
57. N.D. Volkow, J.S. Fowler, G.J. Wang, E. Shumay, F. Telang, P.K. Thanos, and D. Alexoff Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications PLoS One 5 2010 e15269
58. A. Volterra, and J. Meldolesi Astrocytes, from brain glue to communication elements: the revolution continues Nat. Rev. Neurosci. 6 2005 626 640 (Pubitemid 41059337)
59. Z. Wang, O. Pekarskaya, M. Bencheikh, W. Chao, H.A. Gelbard, A. Ghorpade, J.D. Rothstein, and D.J. Volsky Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120 Virology 312 2003 60 73 (Pubitemid 36918460)
60. Z. Xie, and G.M. Miller Trace amine-associated receptor 1 is a modulator of the dopamine transporter J. Pharmacol. Exp. Ther. 321 2007 128 136 (Pubitemid 46456985)
61. Y. Yang, O. Gozen, S. Vidensky, M.B. Robinson, and J.D. Rothstein Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1 Glia 58 2010 277 286
62. J. Zschocke, C. Allritz, J. Engele, and T. Rein DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells Glia 55 2007 663 674 (Pubitemid 46663020)
63. R. Zucchi, G. Chiellini, T.S. Scanlan, and D.K. Grandy Trace amine-associated receptors and their ligands Br. J. Pharmacol. 149 2006 967 978 (Pubitemid 44950800)